Follow the PCI Biotech Holding ASA share price and the full insider trade history of the company, a listed equity based in Norway. Shares are listed on the NO market, under the oversight of Oslo Børs. Operating in the Health Care sector, PCI Biotech Holding ASA has recorded 7 public disclosures. Market capitalisation: €2.6m. The latest transaction was filed on 10 January 2025 (Sale). Among the most active insiders: PCI Biotech. The full history is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
7 of 7 declarations
PCI Biotech Holding ASA es una empresa biofarmacéutica noruega centrada en el desarrollo de tratamientos innovadores para el cáncer. Utiliza tecnología de fototerapia para mejorar la eficacia de los fármacos anticancerígenos.